CME and CFTC at Odds Over On-Chain Perpetual Futures

The Commodity Futures Trading Commission's decision to allow blockchain-based perpetual futures products has sparked a heated battle with the CME Group, the largest derivatives exchange operator in the US. The CME has filed a lawsuit against the CFTC, arguing that the regulator is misapplying the law by permitting products that do not have an end date, which is a key characteristic of traditional futures contracts. The dispute centers on the CFTC's approval of crypto perpetual futures, also known as perps, which are decentralized derivative contracts that enable users to speculate on the price of an asset with leverage and no expiration date. The CME claims that these products are harmful to its long-dated futures products and that the CFTC's sudden embrace of them did not consider the potential consequences. The regulator's move has been seen as a significant development in the rapidly growing crypto derivatives market, with non-US perps volume reportedly reaching $60 trillion in volume last year. The CME's lawsuit argues that the CFTC is mislabeling perps as futures, which would require them to have an end date, and that the regulator's decision to allow these products did not follow the proper protocol. The CFTC's chairman, Mike Selig, has defended the agency's decision, stating that the CME's opposition to perps is 'wholly inappropriate.' The dispute has significant implications for the US approach to the crypto derivatives market, with some arguing that the CFTC's move could pave the way for greater innovation and competition, while others see it as a threat to traditional financial markets. The CME's lawsuit is currently awaiting federal court action, which could have far-reaching consequences for the US crypto derivatives market.